Filing Flows › Comparisons › GOSS vs CPIX
Gossamer Bio vs Cumberland Pharmaceuticals: GOSS and CPIX compared
Gossamer Bio is the larger company: $9.2M of revenue in its latest quarter (Q2 2026) against $8.8M for Cumberland Pharmaceuticals (Q2 2026). Cumberland Pharmaceuticals is growing faster (-19% against -20% a year earlier). Cumberland Pharmaceuticals is more profitable, with an operating margin of -35.9% against -282.2%.
Where the money goes: GOSS and CPIX
Gossamer Bio (GOSS) · Q2 2026
Gossamer Bio, Q2 2026: revenue $9.2M (-20% year over year), operating margin -282.2%, net earnings $16.9M, operating cash flow −$39.4M. The chart follows the revenue to costs, profit and cash.
Cumberland Pharmaceuticals (CPIX) · Q2 2026
Cumberland Pharmaceuticals, Q2 2026: revenue $8.8M (-19% year over year), operating margin -35.9%, net loss $4.3M, operating cash flow $169K. The chart follows the revenue to costs, profit and cash.
| Gossamer Bio (GOSS) | Cumberland Pharmaceuticals (CPIX) | |
|---|---|---|
| Latest quarter | Q2 2026 | Q2 2026 |
| Revenue | $9.2M | $8.8M |
| Revenue growth, Y/Y | -20% | -19% |
| Operating margin | -282.2% | -35.9% |
| Net earnings | $16.9M | −$4.3M |
| Net margin | 182.9% | -48.6% |
| Operating cash flow | −$39.4M | $169K |
| Free cash flow | — | $130K |
Where the revenue comes from
Cumberland Pharmaceuticals
- Talicia: $2.3M (27%)
- Sancuso: $1.8M (21%)
- Vibativ: $1.7M (20%)
- Caldolor: $1.5M (17%)
Questions
Which is bigger, Gossamer Bio or Cumberland Pharmaceuticals?
Gossamer Bio is the larger company: $9.2M of revenue in its latest quarter (Q2 2026) against $8.8M for Cumberland Pharmaceuticals (Q2 2026).
Is Gossamer Bio or Cumberland Pharmaceuticals growing faster?
Cumberland Pharmaceuticals is growing faster (-19% against -20% a year earlier).
Which is more profitable, Gossamer Bio or Cumberland Pharmaceuticals?
Cumberland Pharmaceuticals is more profitable, with an operating margin of -35.9% against -282.2%.
More: Gossamer Bio earnings · how Gossamer Bio makes money · Cumberland Pharmaceuticals earnings · how Cumberland Pharmaceuticals makes money
From the companies' latest 10-Q, 10-K or earnings release (10-Q filed Aug 13, 2026; 10-Q filed Aug 7, 2026). Fiscal quarters can end on different dates. Not investment advice.